# LANSOPRAZOLE
> **ANDA201921** · Abbreviated New Drug Application (Generic) · Sponsor: NATCO PHARMA LTD · Approved 2012-12-18
## Drug
- **FDA Application Number:** ANDA201921
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LANSOPRAZOLE
- **Generic name:** Lansoprazole
- **Active ingredients:** LANSOPRAZOLE
- **Dosage form:** CAPSULE, DELAYED REL PELLETS
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NATCO PHARMA LTD
- **First approval:** 2012-12-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201921)
---
*AI Analytics · CC0 1.0*